Unlike the previous authors, Dr. Cowam in his paper concludes that: "This study found that low-dose spinal opioids did not have a negative impact of neonatal conditions when it was determined using the APGAR score", and he goes on to add that his results were consistent with those of other authors.
A diferencia de las anteriores referencias el Dr. Cowam en su escrito nos concluye: “Este estudio encontró que bajas dosis de opioide espinal no tienen efectos adversos de impacto en la condición neonatal determinada por puntuación de APGAR”, e incluso añade la concordancia con otros autores.